Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 217,768 |
|
|||||
| News | - | ||||||
| Day High | 3.785 | Low High |
|||||
| Day Low | 3.51 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Design Therapeutics Inc | DSGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.13 | 3.56% | 3.78 | 18:48:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.59 | 3.51 | 3.785 | 3.76 | 3.65 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,458 | 217,768 | $ 3.69 | $ 803,548 | - | 1.94 - 8.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:59:00 | formt | 100 | $ 3.78 | USD |
Design Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 211.13M | 56.00M | - | 0 | -66.86M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Design Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DSGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.91 | 3.97 | 3.51 | 3.73 | 254,238 | -0.13 | -3.32% |
| 1 Month | 3.90 | 4.145 | 3.45 | 3.79 | 291,471 | -0.12 | -3.08% |
| 3 Months | 2.40 | 4.145 | 2.245 | 3.28 | 269,550 | 1.38 | 57.50% |
| 6 Months | 2.08 | 4.145 | 1.96 | 2.68 | 346,450 | 1.70 | 81.73% |
| 1 Year | 6.17 | 8.47 | 1.94 | 3.04 | 467,958 | -2.39 | -38.74% |
| 3 Years | 19.23 | 29.16 | 1.94 | 8.50 | 328,382 | -15.45 | -80.34% |
| 5 Years | 28.00 | 50.00 | 1.94 | 8.94 | 326,676 | -24.22 | -86.50% |
Design Therapeutics Description
| Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. |
